AMPAC Fine Chemicals Plans Expansions In California And Texas
According to the company, the expansion projects served to increase total capacities by 50% since 2013.
"AFC is witnessing robust customer demand for our core technologies combined with our development & manufacturing expertise to support drug candidate maturation from clinical trials into commercial production," reports Dr. Aslam Malik, CEO of AMPAC Fine Chemicals.
"To meet this demand, we are investing over $40M in 2016 for capacity expansion and infrastructure enhancements. AFC's plant expansion is supported by the financial backing of H.I.G. Capital, a major international investment firm with $19B under management." adds Dr. Malik.
"New facilities add nine reactors (500 – 2000 gal), Heinkel® Hastelloy® (HF-800) centrifuges plus additional solids handing and processing equipment necessary to support on-going production of cGMP intermediates and APIs," shares Joseph Campbell, AFC VP of Operations and Engineering. "These two facilities benefit from AFC's extensive experience in elimination of Foreign Object & Debris (FOD) and containment of potent compounds," adds Mr. Campbell.
Supply Chain Bottlenecks Creating New “Logistical Hotspots”
The “Great Resignation” Is Impacting Corporate Relocations
Workforce Q4 2021
Changes in the Incentives Landscape
2020 Top States for Doing Business Showcase Their Pro-Business Environments
2021 Gold & Silver Shovel Awards Recognize State and Local Economic Development Efforts
How an International Business Can Enter the U.S. Market Via M&A